AHL
MDGL icon

Abel Hall LLC’s Madrigal Pharmaceuticals MDGL Stock Holding History

Abel Hall LLC’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$746K Buy
1,389
+118
+9% +$60.4K 0.13% 130
2026
Q1 		$665K Buy
1,271
+561
+79% +$268K 0.14% 126
2025
Q4 		$413K Buy
710
+120
+20% +$61.3K 0.1% 221
2025
Q3 		$271K Buy
+590
New +$220K 0.11% 196

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Abel Hall LLC's MDGL Position: Q2 2026 in Review

Abel Hall LLC increased its Madrigal Pharmaceuticals (MDGL) stake by 9.3% in Q2 2026, buying an estimated $60.4K and bringing the position to 1,389 shares worth $746K. The position accounts for 0.13% of the portfolio, ranked #130.

Abel Hall LLC first reported a position in MDGL in Q3 2025 and has held it in 4 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Abel Hall LLC held 1,389 shares of Madrigal Pharmaceuticals worth $746K as of Q2 2026.
  • Abel Hall LLC bought 118 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $60.4K.
  • Madrigal Pharmaceuticals made up 0.13% of Abel Hall LLC's portfolio in Q2 2026, its #130 holding.
  • Abel Hall LLC first reported a position in Madrigal Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.